Mednet Logo
CommunityNeurology

What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?

Community PollStarted

After initiating a patient on anti-amyloid antibody therapy, what are the biggest logistical barriers to ensuring long-term compliance with treatment?

46 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet Member
Neurology · Mount Sinai
Answered on

I would use the same criteria for AAA treatment as those required for entering AAA clinical trials. Overall, our center has not had difficulty with ensuring that patients have timely MRIs before treatments. I enlist caregivers and patients to remind me when they are scheduled for their next infusion...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · The University of Virginia
Answered on

Proper and expedited selection of subjects is fundamental. It is crucial to have processes in place to assure safety monitoring and follow-up in case of adverse events.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Neurology · Your Memory Doctor
Answered on

Adequate training of radiologists is my biggest barrier. I've had even radiologists who were part of the CLARITY-AD study miss superficial siderosis, which I believe would have been criteria to disenroll them.

I've had radiologists who said they were part of AAA trials miss ARIA.

I also just recently ...

Join for free or sign in to see the full answer